: Review of literature on the effectiveness
calcium, hormone replacement therapy (HRT), bisphosphonates, selective modulators
receptors estrogen and calcitonin in the prevention and treatment
postmenopausal osteoporosis. : Materials are specified in the search
in MEDLINE (1966-July 2002), EMBASE (1980-July 2002), and
International Pharmaceutical Abstracts (1970-July 2002)
databases using the key words osteoporosis after menopause, fractures, calcium,
vitamin D, hormone replacement therapy, bisphosphonates, alendronate,
ryzedronat, raloksifen and calcitonin. Additional references were located by analyzing
bibliographies of articles cited. Queries were
limited by time constraints, language and human subject. Experimental and observational studies
using calcium and antiresorptive therapy
prevention and treatment of osteoporosis were selected.
included in this review. : HRT, bisphosphonates, and raloksifen
calcitonin have demonstrated stabilization and improvement ABOUT. Randomized clinical trials have shown reduced risk of fractures with bisphosphonates
, raloksifen, HRT, calcium and calcitonin. The greatest risk reduction
were reported using bisphosphonates lasix 40 mg daily in several trials >>. <<: Several therapeutic possibilities with
well-documented improvements in ON and reduce the risk of fractures is
for women to prevent and treat osteoporosis >>. <<.
No comments:
Post a Comment